COVID-19 trials registries data warehouse

https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-005961-16/DK

Aarhus University Hospital - Department of Infectious Diseases

KRTHAS@rm.dk

2020-12-15

Completed

RCT

Randomized

Crossover

Blind label

single-center

Long covid

1. Age above 18 years. 2. Able to give informed consent. 3. History of documented SARS-CoV-2 infection either by RT-PCR or antibody test. 4. Symptoms related to LTC, defined as being investigated, diagnosed and followed by specialized infectious diseases physicians in the Long Term COVID-19 Outpatient Clinic, Central Region of Denmark, Aarhus University Hospital. This clinic covers all LTC patients referred from general practitioners and regional hospitals in Region Midtjylland. 5. Symptoms not attributable to other co-morbidity/condition.

1. Symptoms of acute COVID-19, as defined by The Danish Health Authorities/Sundhedsstyrelsen. 2. Pregnant or breast-feeding women. 3. Known allergy to soy or peanuts. 4. Individuals with reduced kidney or liver-function. 5. Patients in anticoagulant therapy with warfarin or similar vitamin K antagonists. 6. Any condition that, in the Investigator's opinion, will prevent adequate compliance with study therapy.

2

Lars Jørgen Østergaard

18

100

Denmark

Patients recovered from covid

N/A

120

Number and severity of self-reported symptoms of LTC, measured by self-reporting in questionnaires before and after 6 weeks of CoQ10, measured by symptoms score.

Declared number of arm (3.0) differs from found arms (2.0)

Phase 2

[{"arm_notes": "", "treatment_id": 1326, "treatment_name": "Ubidecarenone", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]